The Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015

JurisdictionUK Non-devolved
CitationSI 2015/704
Year2015

2015No. 704

DANGEROUS DRUGS

The Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015

12thMarch2015

17thMarch2015

31stMay2015

The Secretary of State, after consultation with the Advisory Council on the Misuse of Drugs, makes the following Order in exercise of the powers conferred by section 7(4) and (5) of the Misuse of Drugs Act 1971( 1).

Citation, commencement and extent

1.-(1) This Order may be cited as the Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015 and comes into force on 31st May 2015.

(2) This Order extends to England and Wales and Scotland.

Designation of controlled drugs

2.-(1) The controlled drugs specified in Part 1 of Schedule 1 are designated as drugs to which section 7(4) of the Misuse of Drugs Act 1971 applies.

(2) Part 2 of Schedule 1 has effect for the purpose of specifying those controlled drugs which are excepted from Part 1 of that Schedule.

Revocations

3. The Orders specified in Schedule 2 are revoked.

Lynne Featherstone

Minister of State

Home Office

12th March 2015

SCHEDULE 1

Article 2

CONTROLLED DRUGS TO WHICH SECTION 7(4) OF THE MISUSE OF DRUGS ACT 1971 APPLIES

1. The following substances and products, namely:-

(a) Bufotenine

1,4-Butanediol

Cannabinol

Cannabinol derivatives not being dronabinol or its stereoisomers

Cannabis (not being the substance specified in paragraph 4 of Part 2 of this Schedule)

Cannabis resin

Cathinone

Coca leaf

Concentrate of poppy-straw

Eticyclidine

Etryptamine

Fungus (of any kind) which contains psilocin or an ester of psilocin

Gamma-butyrolactone

Khat

Lysergamide

Lysergide and otherN-alkyl derivatives of lysergamide

Mescaline

Methcathinone

Psilocin

Raw opium

Rolicyclidine

Tenocyclidine

(6aR,9R)-4-acetyl-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (ALD-52)

4-Bromo-2,5-dimethoxy-a-methylphenethylamine

1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)

3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921)

(6aR,9R)-N,N-diethyl-7-allyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (AL-LAD)

(6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (ETH-LAD)

(6aR,9R)-N,N-diethyl-7-propyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide (PRO-LAD)

N,N-Diethyltryptamine

2-((Dimethylamino)methyl)-1-(3-hydroxyphenyl)cyclohexanol

2,4-dimethylazetidinyl{(6aR,9R)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinolin-9-yl}methanone (LSZ)

N,N-Dimethyltryptamine

2,5-Dimethoxy-???,4-dimethylphenethylamine

N-Hydroxy-tenamphetamine

4-Methyl-aminorex

4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4'-DMAR)

(b) Any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by modification in any of the following ways, that is to say-(i) by substitution at the nitrogen atom of the sidechain to any extent with alkyl or alkenyl substituents, or by inclusion of the nitrogen atom of the side chain (and no other atoms of the side chain) in a cyclic structure;(ii) by substitution at the carbon atom adjacent to the nitrogen atom of the side chain with alkyl or alkenyl substituents;(iii) by substitution in the 6-membered ring to any extent with alkyl, alkoxy, haloalkyl, thioalkyl, alkylenedioxy, or halide substituents;(iv) by substitution at the 2-position of the tryptamine ring system with an alkyl substituent;(c) the following phenethylamine derivatives, namely-

Allyl(???-methyl-3,4-methylenedioxyphenethyl)amine

2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethanol

2-Amino-1-(3,4-dimethoxyphenyl)ethanol

Benzyl(???-methyl-3,4-methylenedioxyphenethyl)amine

4-Bromo-???,2,5-trimethoxyphenethylamine

N-(4- sec-Butylthio-2,5-dimethoxyphenethyl)hydroxylamine

Cyclopropylmethyl(??? -methyl-3,4-methylenedioxyphenethyl)amine

2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)ethylamine

2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)-1-methylethylamine

2-(2,5-Dimethoxy-4-methylphenyl)cyclopropylamine

2-(1,4-Dimethoxy-2-naphthyl)ethylamine

2-(1,4-Dimethoxy-2-naphthyl)-1-methylethylamine

N-(2,5-Dimethoxy-4-propylthiophenethyl)hydroxylamine

2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)ethylamine

2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)-1-methylethylamine

???,???-Dimethyl-3,4-methylenedioxyphenethylamine

???,???-Dimethyl-3,4-methylenedioxyphenethyl(methyl)amine

Dimethyl(???-methyl-3,4-methylenedioxyphenethyl)amine

N-(4-Ethylthio-2,5-dimethoxyphenethyl)hydroxylamine

4-Iodo-2,5-dimethoxy-???-methylphenethyl(dimethyl)amine

2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)ethylamine

2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)-1-methylethylamine

2-(5-Methoxy-2,2-dimethyl-2,3-dihydrobenzo[b]furan-6-yl)-1-methylethylamine

2-Methoxyethyl(???-methyl-3,4-methylenedioxyphenethyl)amine

2-(5-Methoxy-2-methyl-2,3-dihydrobenzo[b]furan-6-yl)-1-methylethylamine

???-Methoxy-3,4-methylenedioxyphenethylamine

1-(3,4-Methylenedioxybenzyl)butyl(ethyl)amine

1-(3,4-Methylenedioxybenzyl)butyl(methyl)amine

2-(???-Methyl-3,4-methylenedioxyphenethylamino)ethanol

???-Methyl-3,4-methylenedioxyphenethyl(prop-2-ynyl)amine

N-Methyl- N-(???-methyl-3,4-methylenedioxyphenethyl)hydroxylamine

O-Methyl- N-(???-methyl-3,4-methylenedioxyphenethyl)hydroxylamine

???-Methyl-4-(methylthio)phenethylamine

???,3,4,5-Tetramethoxyphenethylamine

???,2,5-Trimethoxy-4-methylphenethylamine;

(d) any compound (not being methoxyphenamine or a compound for the time being specified in sub-paragraph (a) above) structurally derived from phenethylamine, anN-alkylphenethylamine, ???-methylphenethylamine, an N-alkyl-???-methylphenethylamine, ???-ethylphenethylamine, or an N-alkyl-???-ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substitutents, whether or not further substituted in the ring by one or more other univalent substitutents;(e) any compound (not being a compound for the time being...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT